Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Bering Capital is a venture capital firm located in San Francisco, California, dedicated to investing in biotech and medical technology companies. Founded to transform innovative ideas into successful ventures, the firm draws on the experience and insights gained from early pioneers in Silicon Valley and the broader venture capital landscape. Bering Capital has established itself as a key player in the North American market, focusing on sectors that are critical to advancing healthcare.
The firm has built a notable portfolio that reflects its commitment to supporting groundbreaking innovations in healthcare. Bering Capital's approach combines deep industry knowledge with a network of relationships that enhance its ability to identify and nurture promising startups. The firm operates from its headquarters at 601 California Street, Suite 620, San Francisco, CA 94108, and can be reached at (415) 484-1221.
Bering Capital focuses on investing in cutting-edge biotech and medical technology companies. The firm emphasizes identifying critical problems and knowing when to act, with a strong focus on extraordinary entrepreneurs and innovative solutions within the healthcare sector. Bering Capital seeks to partner with companies that are developing transformative technologies and therapies that address significant medical needs.
The firm typically invests in early-stage companies, providing them with the necessary capital and strategic guidance to navigate the complexities of the healthcare market. Bering Capital's investment strategy is characterized by a hands-on approach, where they actively engage with portfolio companies to help them achieve their goals and maximize their potential.
Bering Capital's portfolio includes several notable companies that are making significant strides in the biotech and healthcare sectors. Key portfolio companies include:
In addition to its current investments, Bering Capital has a history of successful exits, including:
Evgeny Zaytsev, MD, PhD - Managing Partner. Dr. Zaytsev brings extensive experience in the biotech sector, having previously worked with leading firms in venture capital and healthcare innovation.
Philip Sawyer - Managing Partner. Sawyer has a strong background in investment management and has been involved in numerous successful biotech ventures.
Christopher Alafi, DPhil - Advisor. Alafi has a deep understanding of the pharmaceutical industry and has contributed to various successful biotech projects.
George Painter, PhD - Advisor. Dr. Painter is recognized for his expertise in drug development and has held leadership roles in several biotech companies.
Stephen A. Sherwin, MD - Advisor. Dr. Sherwin has a distinguished career in medicine and biotech, providing valuable insights into healthcare investments.
Gregory B. Brown, MD - Advisor. Dr. Brown's background in clinical research and drug development enhances Bering Capital's investment strategy.
What are Bering Capital's investment criteria?
Bering Capital invests primarily in biotech and medical technology companies that demonstrate innovative solutions to critical healthcare problems. The firm looks for extraordinary entrepreneurs who have a clear vision and the capability to execute their ideas.
How can I pitch to Bering Capital?
Founders can pitch to Bering Capital by reaching out through their website or via email. A well-prepared pitch deck should include information about the team, market opportunity, product details, and financial projections.
What makes Bering Capital different from other VCs?
Bering Capital distinguishes itself through its deep focus on the biotech and healthcare sectors, leveraging extensive industry knowledge and a network of relationships to support portfolio companies effectively.
What is the geographic scope of Bering Capital's investments?
The firm primarily invests in North America, concentrating on companies that are developing innovative healthcare solutions.
What is Bering Capital's approach to post-investment involvement?
Bering Capital takes an active role in supporting its portfolio companies, providing mentorship, operational support, and follow-on investment opportunities to help them scale successfully.
What is the typical check size for investments?
While specific check sizes are not disclosed, Bering Capital focuses on early-stage investments, which typically range from seed funding to Series A rounds.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.